2021
DOI: 10.1007/s11892-021-01389-1
|View full text |Cite
|
Sign up to set email alerts
|

Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 55 publications
1
9
0
Order By: Relevance
“…We believe this analysis is a conservative estimate of the cost savings regarding the fnancial implications of rtCGM use. Tese fndings are consistent with previous research reporting that CGM alone signifcantly improves diabetes-related clinical outcomes and overall health care costs [1,7,17,22,23].…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…We believe this analysis is a conservative estimate of the cost savings regarding the fnancial implications of rtCGM use. Tese fndings are consistent with previous research reporting that CGM alone signifcantly improves diabetes-related clinical outcomes and overall health care costs [1,7,17,22,23].…”
Section: Discussionsupporting
confidence: 88%
“…Te ADA frst recommended CGM use for all children and adolescents with T1D in 2018 [12] and continues to endorse this recommendation [13]. However, despite CGM now being accepted in global standards of care [14,15], it is still underutilized in AYA for a multitude of reasons, including device intricacies, costprohibitive access, or various social determinants of health and related disparities [16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…Continuous glucose monitoring (CGM) provides serial interstitial glucose measurements in a noninvasive manner through a wearable device called a continuous glucose monitor (1-3). An advantage of continuous glucose monitoring is to have real time information about glycemic excursions that can be aligned with activities of daily living to support glycemic control among individuals living with diabetes (2)(3)(4). Various CGM are approved by the U.S Food and Drug Administration (FDA) for use in youth with diabetes, however little is known about the role and utility of CGM in the management of youth with obesity without diabetes (5).…”
Section: Introductionmentioning
confidence: 99%
“…While there was a wide variety of CGM uses and outcome metrics in adults, there were very few studies conducted in pediatric populations (5). Only eight studies in children and adolescents were identified, and all were relatively small (n = 17-118) and of very short duration (range of CGM wear = one to eight days) (3)(4)(5)(6)(7)(8). When considering the use of CGM in adolescents without diabetes, many factors must be considered including the feasibility and acceptability of daily wear and the selection of metrics extracted from CGM.…”
Section: Introductionmentioning
confidence: 99%
“…Young adulthood is a high-risk time for T1D management (American Diabetes Association, 2021b), as young adults with T1D have higher glycated hemoglobin levels (average glucose over 2–3 months) than any other age group, have greater diabetes distress than those over 30, they experience T1D complications at a high rate (Dabelea et al, 2017; Iyengar et al, 2019), and they experience more frequent hospital visits (McCarthy & Grey, 2018; Vallis et al, 2018; Wysocki et al, 1996). Young adults are also less likely to use recent technologies effectively (Datye et al, 2021) including continuous glucose monitoring (CGM) devices that provide greater control of glucose levels (Garg et al, 2007). In the current study, we define young adulthood as 18–37 years of age, which is similar to other studies of young people with T1D (see Aina-Popoola, 2017; Helgeson, 2017).…”
mentioning
confidence: 99%